See Allo

Anastasia Putri, author

The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients

University of Indonesia. Faculty of Medicine, 2019

Artikel Jurnal

Radinal Mauludi, author

Korelasi Ekspresi Protein HIF-2 Alfa dengan Rasio BCR-ABL/ABL pada Pasien LGK Fase Kronik yang Mendapat Hidroksia Urea sebelum Imatinib Mesilate = HIF-2 Alpha Protein Expression Correlation with BCR-ABL/ABL ratio in CML Chronic Phase Patients who Received Hydroxy Urea before Imatinib Mesilate

Fakultas Kedokteran Universitas Indonesia, 2022

UI - Tugas Akhir

Hilman Tadjoedin, author

Peran Mutasi Gen BCR-Abl pada Perjalanan Klinis Pasien Leukemia Granulositik Kronik (LGK): Kaitannya dengan Aspek Terapi Imatinib Mesylate (IM) = The Role of BCR-Abl Gene Mutation in Clinical Course of Chronic Myeloid Leukemia Patients (CML): Relation to Aspects of Imatinib Mesylate Therapy (IM)

Fakultas Kedokteran Universitas Indonesia, 2015

UI - Disertasi (Membership)

Nisha Virginia, author

Kualitas hidup dan tingkat kepatuhan penggunaan imatinib mesilat pada pasien Leukemia Granulositik Kronik di RS Kanker Dharmais Jakarta = Quality of life and adherence to imatinib mesylate therapy inchronic myeloid Leukemia Patients at Dharmais Cancer Hospital Jakarta

Fakultas Farmasi Universitas Indonesia, 2020

UI - Tesis (Membership)

Reni Widyastuti, author

Hubungan Mutasi T315I Gen ABL1 dengan Pencapaian Major Molecular Response (MMR) pada Pasien Leukemia Granulositik Kronik Fase Kronik yang Mendapat Imatinib = Association between T315I Mutation in ABL1 Gene to the Achievement of Major Molecular Response (MMR) in Chronic Phase of Chronic Myeloid Leukemia Patients Treated with Imatinib

Fakultas Kedokteran Universitas Indonesia, 2019

UI - Tugas Akhir

<< 1 2 3 >>